(MedPage Today) -- Canadians comprised about 6% of the total enrollment in the ARISTOTLE trial, and their results were representative of the Canadian population as a whole, reported Justin Ezekowitz, MD, at the Canadian Cardiovascular Congress in Vancouver.
Júlio Leonardo B. Pereira
No comments:
Post a Comment